David J Grampovnik

USPTO Granted Patents = 19 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 7)

EPO Patents = 14 (Patent Applications = 11)

Average Co-Inventor Count = 8.7

ph-index = 5

Forward Citations = 116(Granted Patents)

Location History:

North Chicago, IL (US) (1980)
Waukegan, IN (US) (2015)
Waukegan, IL (US) (1997 - 2016)

Company Filing History:

13 out of 4,177

Abbott Laboratories Corporation

Enanta Pharmaceuticals, Inc.

patents

4. 1 out of 61

Reata Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1980-2016

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9464082 - Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2016-10-11),

2. 9309279 - Macrocyclic hepatitis C serine protease inhibitors (2016-04-12),

3. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors (2015-02-10),

4. 8653141 - HIV protease inhibiting compounds (2014-02-18),

5. 8642538 - Macrocyclic hepatitis C serine protease inhibitors (2014-02-04),

6. 8426388 - Prodrugs of HIV protease inhibitors (2013-04-23),

7. 8420596 - Macrocyclic hepatitis C serine protease inhibitors (2013-04-16),

8. 8193227 - HIV protease inhibiting compounds (2012-06-05),

9. 7915411 - Anti-viral compounds (2011-03-29),

10. 7910595 - Anti-viral compounds (2011-03-22),

11. 7834043 - HIV protease inhibiting compounds (2010-11-16),

12. 7718633 - Prodrugs of HIV protease inhibitors (2010-05-18),

13. 7696226 - HIV protease inhibiting compounds (2010-04-13),

14. 6831096 - Inhibitors of neuraminidases (2004-12-14),

15. 6518305 - Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases (2003-02-11),

Title: A Closer Look at David J Grampovnik: Pioneering Innovator in Biomedical Research

Introduction: David J Grampovnik, a distinguished inventor based in Waukegan, IL, has left an indelible mark in the field of biomedical research with his groundbreaking innovations and numerous patents.

Latest Patents: Grampovnik's recent patents highlight his expertise in developing cutting-edge solutions for treating diseases associated with oxidative stress and inflammation. His inventions include compounds such as aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators, as well as macrocyclic hepatitis C serine protease inhibitors.

Career Highlights: With an impressive portfolio of 19 patents, Grampovnik has revolutionized the healthcare industry with his novel approaches to drug development. Having worked at esteemed companies like Abbott Laboratories and AbbVie Inc., he has demonstrated a keen understanding of pharmaceutical research and development.

Collaborations: Throughout his career, Grampovnik has collaborated closely with accomplished professionals in the field, including coworkers such as Dale J Kempf and Hui-Ju J Chen. These collaborations have been instrumental in advancing his innovative research initiatives and bringing his inventions to fruition.

Conclusion: David J Grampovnik's contributions to biomedical research underscore his commitment to advancing medical science and improving patient outcomes. His inventive spirit and collaborative approach continue to inspire the next generation of innovators in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.